000 01420 a2200385 4500
005 20250513221059.0
264 0 _c20001208
008 200012s 0 0 eng d
022 _a0303-7207
024 7 _a10.1016/s0303-7207(00)00291-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFelberbaum, R E
245 0 0 _aClinical application of GnRH-antagonists.
_h[electronic resource]
260 _bMolecular and cellular endocrinology
_cAug 2000
300 _a9-14 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aEndometriosis
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFollicle Stimulating Hormone
_xadministration & dosage
650 0 4 _aGonadotropin-Releasing Hormone
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aLeiomyoma
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMenotropins
_xadministration & dosage
650 0 4 _aNeoplasms, Hormone-Dependent
_xdrug therapy
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aOvulation Induction
_xmethods
650 0 4 _aPituitary Gland
_xdrug effects
650 0 4 _aProstatic Neoplasms
_xdrug therapy
700 1 _aLudwig, M
700 1 _aDiedrich, K
773 0 _tMolecular and cellular endocrinology
_gvol. 166
_gno. 1
_gp. 9-14
856 4 0 _uhttps://doi.org/10.1016/s0303-7207(00)00291-4
_zAvailable from publisher's website
999 _c10935645
_d10935645